BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 26831834)

  • 1. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.
    Ahn SY; Yoon SH; Yang BR; Kim YT; Park CM; Goo JM
    Eur Radiol; 2019 Jan; 29(1):270-278. PubMed ID: 29948086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
    Moon Y; Park JK; Lee KY; Sung SW
    Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up.
    Maeda R; Yoshida J; Hishida T; Aokage K; Nishimura M; Nishiwaki Y; Nagai K
    Chest; 2010 Jul; 138(1):145-50. PubMed ID: 20382716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
    Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
    Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.